Syngenta Anticipates Minimal Impact from US Tariffs on Business by 2025
PorAinvest
martes, 10 de junio de 2025, 12:11 pm ET1 min de lectura
BIOA--
The agricultural biologics market is projected to reach $16.61 billion in 2025, with a compound annual growth rate (CAGR) of 16.0% expected to push this value further to $29.92 billion by 2029 [2]. The growth is driven by factors such as the rise in organic farming practices, heightened awareness of the environmental impact of heavy chemical pesticide and fertilizer use, and an increase in the global population.
Syngenta, like many other major players in the agricultural biologics market, is actively innovating and introducing sustainable solutions. For instance, UK-based biotech firm Bionema UK launched the Biodegradable Surfactant Soil-Jet BSP100 in January 2024, which enhances the efficacy of biological and chemical products while minimizing environmental damage [2].
Despite the investments in biological products, Syngenta's operations are not expected to be significantly affected by the US tariffs. The company's focus on innovation and sustainability aligns with broader trends in the agricultural sector, where there is a growing preference for environmentally friendly solutions.
References:
[1] https://www.business-humanrights.org/en/latest-news/kenya-eu-based-companies-continue-to-export-banned-pesticides-exposing-communities-workers-to-chemical-burns-and-long-term-illness/
[2] https://menafn.com/1109644592/Global-Agricultural-Biologics-Market-Forecast-Key-Growth-Drivers-Trends-And-Opportunities-From-2025-To-2034
Syngenta expects minimal impact from US tariffs on its business in 2025. The company is expanding and investing in biological products, but they do not replace synthetic agricultural chemicals. The tariffs imposed by US President Donald Trump are expected to have a limited effect on Syngenta's operations.
Syngenta, a leading global agribusiness company, expects minimal impact from the US tariffs imposed by President Donald Trump on its business operations in 2025. The company has been expanding and investing in biological products, a sector that is witnessing significant growth due to increasing awareness of the environmental impact of chemical pesticides and fertilizers [2]. However, these biological products are not yet capable of fully replacing synthetic agricultural chemicals.The agricultural biologics market is projected to reach $16.61 billion in 2025, with a compound annual growth rate (CAGR) of 16.0% expected to push this value further to $29.92 billion by 2029 [2]. The growth is driven by factors such as the rise in organic farming practices, heightened awareness of the environmental impact of heavy chemical pesticide and fertilizer use, and an increase in the global population.
Syngenta, like many other major players in the agricultural biologics market, is actively innovating and introducing sustainable solutions. For instance, UK-based biotech firm Bionema UK launched the Biodegradable Surfactant Soil-Jet BSP100 in January 2024, which enhances the efficacy of biological and chemical products while minimizing environmental damage [2].
Despite the investments in biological products, Syngenta's operations are not expected to be significantly affected by the US tariffs. The company's focus on innovation and sustainability aligns with broader trends in the agricultural sector, where there is a growing preference for environmentally friendly solutions.
References:
[1] https://www.business-humanrights.org/en/latest-news/kenya-eu-based-companies-continue-to-export-banned-pesticides-exposing-communities-workers-to-chemical-burns-and-long-term-illness/
[2] https://menafn.com/1109644592/Global-Agricultural-Biologics-Market-Forecast-Key-Growth-Drivers-Trends-And-Opportunities-From-2025-To-2034
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios